A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals’ Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:January 19, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:January 19, 2021Completed
Condition(s):Neoplasms, RectalLast Updated:January 19, 2021Active, not recruiting
Condition(s):Infections, StreptococcalLast Updated:January 13, 2017Completed
Condition(s):Acellular Pertussis; Diphtheria; Tetanus; PoliomyelitisLast Updated:April 25, 2016Completed
Condition(s):Mumps; Rubella; Measles; VaricellaLast Updated:July 22, 2013Withdrawn
Condition(s):Whooping CoughLast Updated:September 11, 2020Completed
Condition(s):Infections, PapillomavirusLast Updated:December 2, 2014Completed
Condition(s):Meningitis; Meningococcal InfectionLast Updated:July 9, 2013Completed
Condition(s):Influenza, HumanLast Updated:February 11, 2019Completed
Condition(s):TetanusLast Updated:May 28, 2020Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.